How long does stem cell therapy for Ulcerative Colitis last?
There is insufficient controlled evidence to establish remission duration after systemic cell therapy or the value of repeat dosing. Background IBD medicines and the disease's fluctuating course affect outcomes. Providers should not promise a response window, maintenance interval or replacement of standard maintenance treatment.
How stem cells are studied for Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory bowel disease affecting the colon and rectum. Mesenchymal stem cell research in UC explores immunomodulatory and tissue-repair mechanisms, but this remains investigational. Darvadstrocel, an MSC product formerly authorised in the EU for complex perianal Crohn's fistulae, had its marketing authorisation withdrawn in December 2024; that former indication did not establish efficacy for ulcerative colitis.
Am I a candidate? → · Ulcerative Colitis: full overview → · Ulcerative Colitis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.